102 related articles for article (PubMed ID: 8512464)
1. Physical incompatibility of vancomycin and ceftazidime for intravitreal injection.
Fiscella RG
Arch Ophthalmol; 1993 Jun; 111(6):730. PubMed ID: 8512464
[No Abstract] [Full Text] [Related]
2. Vancomycin and ceftazidime incompatibility upon intravitreal injection.
Lifshitz T; Lapid-Gortzak R; Finkelman Y; Klemperer I
Br J Ophthalmol; 2000 Jan; 84(1):117-8. PubMed ID: 10691328
[No Abstract] [Full Text] [Related]
3. Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil-filled eye.
Hegazy HM; Kivilcim M; Peyman GA; Unal MH; Liang C; Molinari LC; Kazi AA
Retina; 1999; 19(6):553-7. PubMed ID: 10606458
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis.
Homer P; Peyman GA; Koziol J; Sanders D
Acta Ophthalmol (Copenh); 1975 Jun; 53(3):311-20. PubMed ID: 1101624
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
Reddy AK; Reddy RR; Paruvelli MR; Ambatipudi S; Rani A; Lodhi SA; Reddy JM; Reddy KR; Pandey N; Videkar R; Sinha MK; Majji AB; Deb-Jorder N; Sahu AK; Myneni J; Abraham A
Int Ophthalmol; 2015 Feb; 35(1):37-42. PubMed ID: 25384628
[TBL] [Abstract][Full Text] [Related]
7. Safety of repeated intravitreous injections of antibiotics and dexamethasone.
Yoshizumi MO; Bhavsar AR; Dessouki A; Kashani A
Retina; 1999; 19(5):437-41. PubMed ID: 10546941
[TBL] [Abstract][Full Text] [Related]
8. Re: Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.
Ranchod TM; Leverenz VR; Chintala SK; Cheng M; Trese MT; Giblin FJ
Retina; 2010; 30(10):1752-4; author reply 1754. PubMed ID: 21060278
[No Abstract] [Full Text] [Related]
9. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis.
Ferencz JR; Assia EI; Diamantstein L; Rubinstein E
Arch Ophthalmol; 1999 Aug; 117(8):1023-7. PubMed ID: 10448744
[TBL] [Abstract][Full Text] [Related]
10. Retinal toxicity of intraocular vancomycin and ceftazidime in vitrectomized rabbit eyes.
Sonmez M; Unal MH; Yildiz TF; Gulecek O
Drug Chem Toxicol; 2006 Jan; 29(1):125-34. PubMed ID: 16455595
[TBL] [Abstract][Full Text] [Related]
11. Role of prophylactic intravitreal antibiotics in open globe injuries.
Narang S; Gupta V; Gupta A; Dogra MR; Pandav SS; Das S
Indian J Ophthalmol; 2003 Mar; 51(1):39-44. PubMed ID: 12701861
[TBL] [Abstract][Full Text] [Related]
12. Intraocular inflammation after intravitreal ranibizumab injections.
Fauser S; Schroeder S; Caramoy A; Kirchhof B; Lappas A
Acta Ophthalmol; 2011 Feb; 89(1):e98-9. PubMed ID: 20384590
[No Abstract] [Full Text] [Related]
13. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.
Kwok AK; Hui M; Pang CP; Chan RC; Cheung SW; Yip CM; Lam DS; Cheng AF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1182-8. PubMed ID: 11923264
[TBL] [Abstract][Full Text] [Related]
14. Commentary: Intravitreal moxifloxacin for acute postoperative endophthalmitis: Is it as safe and efficacious as the age-old recommended intravitreal vancomycin and ceftazidime?
Bhojwani D
Indian J Ophthalmol; 2021 Feb; 69(2):330-331. PubMed ID: 33463585
[No Abstract] [Full Text] [Related]
15. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial.
Albrecht E; Richards JC; Pollock T; Cook C; Myers L
Br J Ophthalmol; 2011 Oct; 95(10):1385-8. PubMed ID: 21289020
[TBL] [Abstract][Full Text] [Related]
16. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
[TBL] [Abstract][Full Text] [Related]
17. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.
Diago T; McCannel CA; Bakri SJ; Pulido JS; Edwards AO; Pach JM
Retina; 2009 May; 29(5):601-5. PubMed ID: 19357558
[TBL] [Abstract][Full Text] [Related]
18. [Toxicity of intravitreal injections of antibiotics and antivirals].
Libert J
Bull Soc Belge Ophtalmol; 2007; (304):89-97. PubMed ID: 17718233
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.
Pflugfelder SC; Hernández E; Fliesler SJ; Alvarez J; Pflugfelder ME; Forster RK
Arch Ophthalmol; 1987 Jun; 105(6):831-7. PubMed ID: 3495255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
